Difference between revisions of "Template:COVID-19 Testing, Reporting, and Information Management in the Laboratory/Final thoughts and additional resources/Key guidance documents"
From LIMSWiki
Jump to navigationJump to searchShawndouglas (talk | contribs) (Updated for August) |
Shawndouglas (talk | contribs) m (→5.2 Key guidance documents: Pooled testing guidance) |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
===5.2 Key guidance documents=== | ===5.2 Key guidance documents=== | ||
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/lab/reporting-lab-data.html |title=How to Report COVID-19 Laboratory Data |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date= | * {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/index.html |title=Contact Tracing |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=16 September 2021}} | ||
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/lab/point-of-care-testing.html |title=Guidance for SARS-CoV-2 Point-of-Care and Rapid Testing |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=08 July 2021}} | |||
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html |title=Interim Guidelines for Collecting | * {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/lab/reporting-lab-data.html |title=How to Report COVID-19 Laboratory Data |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=26 January 2021}} | ||
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/lab/pooling-procedures.html |title=Interim Guidance for Use of Pooling Procedures in SARS-CoV-2 Diagnostic and Screening Testing |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=30 June 2021}} | |||
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-nCoV/lab/lab-biosafety-guidelines.html |title=Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19) |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=11 | * {{cite web |url=https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html |title=Interim Guidelines for Collecting and Handling of Clinical Specimens for COVID-19 Testing |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=26 February 2021}} | ||
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-nCoV/lab/lab-biosafety-guidelines.html |title=Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19) |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=11 June 2021}} | |||
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html |title=Overview of Testing for SARS-CoV-2 |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date= | * {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html |title=Overview of Testing for SARS-CoV-2 (COVID-19) |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=02 August 2021}} | ||
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/sars-cov2-testing-strategies.html |title=Testing Strategies for SARS-CoV-2 |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=13 August 2021}} | |||
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/ | * {{cite web |url=https://www.cms.gov/files/document/fy-2022-icd-10-cm-coding-guidelines.pdf |format=PDF |title=ICD-10-CM Official Guidelines for Coding and Reporting - FY 2022 |author=Centers for Medicare & Medicaid Services |publisher=Centers for Medicare & Medicaid Services |date=August 2021}} | ||
* {{cite web |url=https://ec.europa.eu/commission/presscorner/detail/en/QANDA_20_1905 |title=Coronavirus: EU interoperability gateway for contact tracing and warning apps – Questions and Answers |author=European Commission |publisher=European Union |date=19 October 2020}} | |||
* {{cite web |url=https://edpb.europa.eu/sites/ | * {{cite web |url=https://edpb.europa.eu/sites/default/files/files/file1/edpb_guidelines_20200420_contact_tracing_covid_with_annex_en.pdf |format=PDF |title=Guidelines 04/2020 on the use of location data and contact tracing tools in the context of the COVID-19 outbreak |author=European Data Protection Board |publisher=European Union |date=21 April 2020}} | ||
* {{cite web |url=https://www.osha.gov/coronavirus/safework |title=Protecting Workers: Guidance on Mitigating and Preventing the Spread of COVID-19 in the Workplace |author=Occupational Safety and Health Administration |publisher=Occupational Safety and Health Administration |date=13 August 2021}} | |||
* {{cite web |url=https://www.osha.gov/ | * {{cite web |url=https://iris.paho.org/handle/10665.2/52458 |title=Laboratory Guidelines for the Detection and Diagnosis of COVID-19 Virus Infection |author=Pan American Health Organization |publisher=Pan American Health Organization |date=08 July 2020}} | ||
* {{cite web |url=https://www.gov.uk/government/publications/wuhan-novel-coronavirus-guidance-for-clinical-diagnostic-laboratories |title=COVID-19: Guidance for sampling and for diagnostic laboratories |author=Public Health England |publisher=U.K Government |date=29 March 2021}} | |||
* {{cite web |url=https:// | * {{cite web |url=https://www.health.gov.au/resources/publications/phln-guidance-on-laboratory-testing-for-sars-cov-2-the-virus-that-causes-covid-19 |title=PHLN guidance on laboratory testing for SARS-CoV-2 (the virus that causes COVID-19) |author=Public Health Laboratory Network |publisher=Department of Health, Australian Government |date=22 June 2021}} | ||
* {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-face-masks-barrier-face-coverings-face-shields-surgical-masks-and-respirators |title=Enforcement Policy for Face Masks, Barrier Face Coverings, Face Shields, Surgical Masks, and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Revised) |work=FDA-2020-D-1138 |author=U.S. Food and Drug Administration |publisher=U.S. Food and Drug Administration |date=September 2021}} | |||
* {{cite web |url=https://www.gov.uk/government/publications/wuhan-novel-coronavirus-guidance-for-clinical-diagnostic-laboratories |title=COVID-19: Guidance for sampling and for diagnostic laboratories |author=Public Health England |publisher=U.K Government |date= | |||
* {{cite web |url=https://www.health.gov.au/resources/publications/phln-guidance-on-laboratory-testing-for-sars-cov-2-the-virus-that-causes-covid-19 |title=PHLN guidance on laboratory testing for SARS-CoV-2 (the virus that causes COVID-19) |author=Public Health Laboratory Network |publisher=Department of Health, Australian Government |date= | |||
* {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-face-masks- | |||
* {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-gowns-other-apparel-and-gloves-during-coronavirus-disease-covid-19-public-health |title=Enforcement Policy for Gowns, Other Apparel, and Gloves During the Coronavirus Disease (COVID-19) Public Health Emergency |work=FDA-2020-D-1138-0023 |author=U.S. Food and Drug Administration |publisher=U.S. Food and Drug Administration |date=30 March 2020}} | * {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-gowns-other-apparel-and-gloves-during-coronavirus-disease-covid-19-public-health |title=Enforcement Policy for Gowns, Other Apparel, and Gloves During the Coronavirus Disease (COVID-19) Public Health Emergency |work=FDA-2020-D-1138-0023 |author=U.S. Food and Drug Administration |publisher=U.S. Food and Drug Administration |date=30 March 2020}} | ||
* {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-coronavirus-disease-2019-tests-during-public-health-emergency-revised |title=Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised) |work=FDA-2020-D-0987-0049 |author=U.S. Food and Drug Administration |publisher=U.S. Food and Drug Administration |date=15 May 2020}} | |||
* {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy | * {{cite web |url=https://apps.who.int/iris/handle/10665/335843 |title=Assessment tool for laboratories implementing SARS-CoV-2 testing: Interim guidance, 2 October 2020 |work=WHO/2019-nCoV/Lab_Assessment_Tool/2020.2 |author=World Health Organization, et al. |publisher=World Health Organization |date=02 October 2020}} | ||
* {{cite web |url=https://apps.who.int/iris/handle/10665/334254 |title=Diagnostic testing for SARS-CoV-2: Interim guidance, 11 September 2020 |work=WHO/2019-nCoV/laboratory/2020.6 |author=World Health Organization, et al. |publisher=World Health Organization |date=11 September 2020}} | |||
* {{cite web |url=https://apps.who.int/iris/handle/10665/332076 |title=Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 13 May 2020 |work=WHO/WPE/GIH/2020.3 |author=World Health Organization, et al. |publisher=World Health Organization |date=13 May 2020}} | * {{cite web |url=https://apps.who.int/iris/handle/10665/332076 |title=Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 13 May 2020 |work=WHO/WPE/GIH/2020.3 |author=World Health Organization, et al. |publisher=World Health Organization |date=13 May 2020}} | ||
Latest revision as of 16:48, 19 September 2021
5.2 Key guidance documents
- Centers for Disease Control and Prevention (16 September 2021). "Contact Tracing". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/index.html.
- Centers for Disease Control and Prevention (8 July 2021). "Guidance for SARS-CoV-2 Point-of-Care and Rapid Testing". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/lab/point-of-care-testing.html.
- Centers for Disease Control and Prevention (26 January 2021). "How to Report COVID-19 Laboratory Data". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/lab/reporting-lab-data.html.
- Centers for Disease Control and Prevention (30 June 2021). "Interim Guidance for Use of Pooling Procedures in SARS-CoV-2 Diagnostic and Screening Testing". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/lab/pooling-procedures.html.
- Centers for Disease Control and Prevention (26 February 2021). "Interim Guidelines for Collecting and Handling of Clinical Specimens for COVID-19 Testing". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html.
- Centers for Disease Control and Prevention (11 June 2021). "Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-nCoV/lab/lab-biosafety-guidelines.html.
- Centers for Disease Control and Prevention (2 August 2021). "Overview of Testing for SARS-CoV-2 (COVID-19)". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html.
- Centers for Disease Control and Prevention (13 August 2021). "Testing Strategies for SARS-CoV-2". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/sars-cov2-testing-strategies.html.
- Centers for Medicare & Medicaid Services (August 2021). "ICD-10-CM Official Guidelines for Coding and Reporting - FY 2022" (PDF). Centers for Medicare & Medicaid Services. https://www.cms.gov/files/document/fy-2022-icd-10-cm-coding-guidelines.pdf.
- European Commission (19 October 2020). "Coronavirus: EU interoperability gateway for contact tracing and warning apps – Questions and Answers". European Union. https://ec.europa.eu/commission/presscorner/detail/en/QANDA_20_1905.
- European Data Protection Board (21 April 2020). "Guidelines 04/2020 on the use of location data and contact tracing tools in the context of the COVID-19 outbreak" (PDF). European Union. https://edpb.europa.eu/sites/default/files/files/file1/edpb_guidelines_20200420_contact_tracing_covid_with_annex_en.pdf.
- Occupational Safety and Health Administration (13 August 2021). "Protecting Workers: Guidance on Mitigating and Preventing the Spread of COVID-19 in the Workplace". Occupational Safety and Health Administration. https://www.osha.gov/coronavirus/safework.
- Pan American Health Organization (8 July 2020). "Laboratory Guidelines for the Detection and Diagnosis of COVID-19 Virus Infection". Pan American Health Organization. https://iris.paho.org/handle/10665.2/52458.
- Public Health England (29 March 2021). "COVID-19: Guidance for sampling and for diagnostic laboratories". U.K Government. https://www.gov.uk/government/publications/wuhan-novel-coronavirus-guidance-for-clinical-diagnostic-laboratories.
- Public Health Laboratory Network (22 June 2021). "PHLN guidance on laboratory testing for SARS-CoV-2 (the virus that causes COVID-19)". Department of Health, Australian Government. https://www.health.gov.au/resources/publications/phln-guidance-on-laboratory-testing-for-sars-cov-2-the-virus-that-causes-covid-19.
- U.S. Food and Drug Administration (September 2021). "Enforcement Policy for Face Masks, Barrier Face Coverings, Face Shields, Surgical Masks, and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Revised)". FDA-2020-D-1138. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-face-masks-barrier-face-coverings-face-shields-surgical-masks-and-respirators.
- U.S. Food and Drug Administration (30 March 2020). "Enforcement Policy for Gowns, Other Apparel, and Gloves During the Coronavirus Disease (COVID-19) Public Health Emergency". FDA-2020-D-1138-0023. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-gowns-other-apparel-and-gloves-during-coronavirus-disease-covid-19-public-health.
- U.S. Food and Drug Administration (15 May 2020). "Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised)". FDA-2020-D-0987-0049. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-coronavirus-disease-2019-tests-during-public-health-emergency-revised.
- World Health Organization, et al. (2 October 2020). "Assessment tool for laboratories implementing SARS-CoV-2 testing: Interim guidance, 2 October 2020". WHO/2019-nCoV/Lab_Assessment_Tool/2020.2. World Health Organization. https://apps.who.int/iris/handle/10665/335843.
- World Health Organization, et al. (11 September 2020). "Diagnostic testing for SARS-CoV-2: Interim guidance, 11 September 2020". WHO/2019-nCoV/laboratory/2020.6. World Health Organization. https://apps.who.int/iris/handle/10665/334254.
- World Health Organization, et al. (13 May 2020). "Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 13 May 2020". WHO/WPE/GIH/2020.3. World Health Organization. https://apps.who.int/iris/handle/10665/332076.
